Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS (CEC) AND PLASMA ANGIOGENIC FACTORS IN PATIENTS WITH BREAST CANCER
3 other identifiers
observational
50
1 country
1
Brief Summary
RATIONALE: Studying samples of blood in the laboratory from patients with current or previous cancer may help doctors learn more about biomarkers related to cancer. PURPOSE: This research study is looking at blood samples in women with breast cancer or a history of breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2001
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 9, 2009
CompletedFirst Posted
Study publicly available on registry
May 12, 2009
CompletedDecember 17, 2012
December 1, 2012
5.6 years
May 9, 2009
December 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of levels of peripheral blood (PB) circulating endothelial cells (CEC) and plasma angiogenic factors between patients with active, measurable breast cancer vs prior history of breast cancer with no evidence of active disease
Secondary Outcomes (1)
Correlation of CEC and plasma angiogenic factors with response to tumor to a chemotherapy regimen
Interventions
Eligibility Criteria
women with breast cancer or a history of breast cancer
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- University of Arizonalead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, 85724, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alison T. Stopeck, MD
University of Arizona
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 9, 2009
First Posted
May 12, 2009
Study Start
August 1, 2001
Primary Completion
March 1, 2007
Study Completion
March 1, 2007
Last Updated
December 17, 2012
Record last verified: 2012-12